Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Chronic stable angina pectoris~* Documented coronary artery disease~* Previous treatment with atenolol or other beta-blocker agent~* Exercise tolerance test positivity and stability~Exclusion Criteria:~* Heart rate \< 60 bpm~* Congestive heart failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).